Irinotecan cost effective in metastatic colorectal cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1226, 2000-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Colorectal cancer screening cost effective

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 286, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Cost-effective treatments for colorectal cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 646, 2012-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Biologics not cost effective in colorectal cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Triaging for colorectal cancer screening cost effective in UK . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

By Shitara Kohei

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 787-793

Springer Publishing Company

Access to resources Recommend Favorite